Ambrisentan havde heller ingen samlet virkning på den ugentlige dosis af warfarinantikoagulant, protrombintid (PT) og international normalized ratio (INR) hos patienterne.
In addition, in patients, ambrisentan had no overall effect on the weekly warfarin-type anticoagulant dose, prothrombin time (PT) and international normalized ratio (INR).